Inactive Instrument

Insiders NTN Buzztime, Inc.

Equities

NTN

US6294106066

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

NTN Buzztime, Inc. has Changed its Name to Brooklyn ImmunoTherapeutics, Inc	15/03/21	CI
NTN Buzztime, Inc. Announces Board Changes	03/04/20	CI
NTN Buzztime, Inc. Appoints Allen Wolff as Chief Executive Officer and to Its Board of Directors	15/01/20	CI
NTN Buzztime, Inc. Announces Board Changes	26/11/19	CI
NTN Buzztime, Inc. Announces Board Changes	26/11/19	CI
NTN Buzztime Announces Management Changes	17/09/19	CI
NTN Buzztime, Inc. Announces Board Changes	03/09/19	CI
NTN Buzztime, Inc. Announces Termination of Dave Miller, Senior Vice President of Marketing, Effective December 1, 2017	25/10/17	CI
NTN Buzztime, Inc. Announces Board Changes	10/07/17	CI
NTN Buzztime, Inc. Names Allen Wolff as Chief Financial Officer and Executive Vice President	02/02/16	CI
NTN Buzztime Inc. Announces Termination of Robert Cooney as Chief Product Officer, Effective May 22, 2015	14/05/15	CI
NTN Buzztime Inc. Announces Executive Changes, Effective December 29, 2014	19/12/14	CI
NTN Buzztime Inc. Announces Management Changes	08/09/14	CI
Jeff Berg Steps Down as CEO of NTN Buzztime Inc	24/08/14	CI
NTN Buzztime Inc. Appoints Ram Krishnan as New CEO and Board of Director, Effective September 15, 2014	22/08/14	CI
NTN Buzztime Announces Executive Changes	06/06/14	CI
NTN Buzztime Inc. Appoints Bob Cooney as Chief Operating Officer	27/01/14	CI
NTN Buzztime Inc. Appoints Vladimir Khuchua-Edelman as Chief Development Officer	06/01/14	CI
NTN Buzztime Inc. Announces Appointment of Kirk Nagamine as Chief Revenue Officer	16/04/13	CI
NTN Buzztime, Inc. Announces Board Changes	21/03/13	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders NTN Buzztime, Inc.

Equities

NTN

US6294106066

Insiders

Filters